Flexiglim 0.5 Tablet
By Flexiglim
10 Tablet in a Strip

Composition
Glimepiride(0.5mg)

Manufacturer - Torrent Pharmaceuticals Ltd
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after
February, 2027

liver
Caution should be taken when using Flexiglim 0.5 Tablet in individuals with liver disease. It may be necessary to adjust the dosage of the medication. Patients are advised to consult their doctor regarding the use of Flexiglim 0.5 Tablet. However, the medication is not suitable for individuals with severe liver disease as it can lead to significantly low blood sugar levels, which may normalize over time. It is important to note that Flexiglim 0.5 Tablet is not recommended for patients with liver dysfunction, as it could potentially cause liver damage. Remember to seek advice from a healthcare professional before starting Flexiglim 0.5 Tablet if you have any liver concerns.

kidney
Flexiglim 0.5 Tablet should be used carefully in patients with kidney disease. Dose adjustment may be necessary, so consult your doctor. Avoid in severe kidney disease as it may lead to low blood sugar levels. Consult a doctor if you have kidney dysfunction before taking Flexiglim 0.5 Tablet.

alcohol
It is not safe to consume alcohol with Flexiglim 0.5 Tablet. Mixing alcohol with this medication can affect the blood sugar-lowering effects of the tablet in a way that may be harmful.

driving
Caution Driving may be affected by blood sugar levels. Avoid driving if experiencing low or high blood sugar symptoms while using Flexiglim 0.5 Tablet. Not recommended for individuals with fluctuating glucose levels, as it can impair focus and reaction time, posing risks while driving or operating machinery.

pregnancy
Flexiglim 0.5 Tablet may not be safe for use during pregnancy. Limited human studies suggest potential harm to the baby. Your doctor will assess the risks before prescribing. It is classified as Pregnancy Category C, so consult your doctor and discontinue use before delivery.

breastfeeding
Flexiglim 0.5 Tablet is not recommended for breastfeeding mothers as it may pass into breast milk and potentially harm the baby by causing low blood sugar. Monitoring the infant's blood glucose is advised if the mother is on Flexiglim 0.5 Tablet therapy.
Habit Forming | No |
Chemical Class | Third-generation Sulfonylurea Derivative |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹59.73
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024